BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17975551)

  • 1. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.
    McStay GP; Salvesen GS; Green DR
    Cell Death Differ; 2008 Feb; 15(2):322-31. PubMed ID: 17975551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
    Pereira NA; Song Z
    Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apo cytochrome c inhibits caspases by preventing apoptosome formation.
    Martin AG; Nguyen J; Wells JA; Fearnhead HO
    Biochem Biophys Res Commun; 2004 Jul; 319(3):944-50. PubMed ID: 15184073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis.
    Tawa P; Tam J; Cassady R; Nicholson DW; Xanthoudakis S
    Cell Death Differ; 2001 Jan; 8(1):30-7. PubMed ID: 11313700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific proteolysis of the A-kinase-anchoring protein 149 at the Asp582 residue by caspases during apoptosis.
    Yoo H; Cha HJ; Lee J; Yu EO; Bae S; Jung JH; Sohn I; Lee SJ; Yang KH; Woo SH; Seo SK; Park IC; Kim CS; Jin YW; Ahn SK
    Oncol Rep; 2008 Jun; 19(6):1577-82. PubMed ID: 18497968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase assays: identifying caspase activity and substrates in vitro and in vivo.
    Pop C; Salvesen GS; Scott FL
    Methods Enzymol; 2008; 446():351-67. PubMed ID: 18603133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apoptotic effects of oxidative stress and antiapoptotic effects of caspase inhibitors on rat notochordal cells.
    Kim KW; Ha KY; Lee JS; Rhyu KW; An HS; Woo YK
    Spine (Phila Pa 1976); 2007 Oct; 32(22):2443-8. PubMed ID: 18090083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
    Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
    Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide donors inhibit formation of the Apaf-1/caspase-9 apoptosome and activation of caspases.
    Zech B; Köhl R; von Knethen A; Brüne B
    Biochem J; 2003 May; 371(Pt 3):1055-64. PubMed ID: 12605597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine kinase p56lck-deficiency confers hypersusceptibility to rho-fluorophenylalanine (pFPhe)-induced apoptosis by augmenting mitochondrial apoptotic pathway in human Jurkat T cells.
    Park HS; Jun DY; Han CR; Kim YH
    Biochem Biophys Res Commun; 2008 Dec; 377(1):280-5. PubMed ID: 18845126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspases: determination of their activities in apoptotic cells.
    Vaculova A; Zhivotovsky B
    Methods Enzymol; 2008; 442():157-81. PubMed ID: 18662569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of the caspase-9 signaling cascade.
    Guerrero AD; Chen M; Wang J
    Apoptosis; 2008 Jan; 13(1):177-86. PubMed ID: 17899380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP.
    Yang JY; Widmann C
    Mol Cell Biol; 2001 Aug; 21(16):5346-58. PubMed ID: 11463818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Ac-DEVD-N'-(Polyfluorobenzoyl)-R110: novel cell-permeable fluorogenic caspase substrates for the detection of caspase activity and apoptosis.
    Zhang HZ; Kasibhatla S; Guastella J; Tseng B; Drewe J; Cai SX
    Bioconjug Chem; 2003; 14(2):458-63. PubMed ID: 12643757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
    Frydrych I; Mlejnek P
    J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis.
    Van Damme P; Martens L; Van Damme J; Hugelier K; Staes A; Vandekerckhove J; Gevaert K
    Nat Methods; 2005 Oct; 2(10):771-7. PubMed ID: 16179924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis.
    Scott CW; Sobotka-Briner C; Wilkins DE; Jacobs RT; Folmer JJ; Frazee WJ; Bhat RV; Ghanekar SV; Aharony D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):433-40. PubMed ID: 12490620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells.
    Choi EJ; Ahn WS; Bae SM
    Chem Biol Interact; 2009 Jan; 177(1):7-11. PubMed ID: 18973749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and in vivo characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis.
    Bullok KE; Maxwell D; Kesarwala AH; Gammon S; Prior JL; Snow M; Stanley S; Piwnica-Worms D
    Biochemistry; 2007 Apr; 46(13):4055-65. PubMed ID: 17348687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Use of Peptide Based Substrates and Inhibitors of Apoptotic Caspases.
    McStay GP
    Methods Mol Biol; 2016; 1419():57-67. PubMed ID: 27108431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.